Once-weekly GLP-1R agonists: moving the goal posts
- PMID: 29397375
- DOI: 10.1016/S2213-8587(18)30049-4
Once-weekly GLP-1R agonists: moving the goal posts
Comment on
-
Semaglutide versus dulaglutide once weekly in patients with type 2 diabetes (SUSTAIN 7): a randomised, open-label, phase 3b trial.Lancet Diabetes Endocrinol. 2018 Apr;6(4):275-286. doi: 10.1016/S2213-8587(18)30024-X. Epub 2018 Feb 1. Lancet Diabetes Endocrinol. 2018. PMID: 29397376 Clinical Trial.
Similar articles
-
Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials.BMJ. 2012 Jan 10;344:d7771. doi: 10.1136/bmj.d7771. BMJ. 2012. PMID: 22236411 Free PMC article. Review.
-
Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice.EMBO Mol Med. 2015 Mar;7(3):288-98. doi: 10.15252/emmm.201404508. EMBO Mol Med. 2015. PMID: 25652173 Free PMC article.
-
Cardiovascular Actions and Clinical Outcomes With Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors.Circulation. 2017 Aug 29;136(9):849-870. doi: 10.1161/CIRCULATIONAHA.117.028136. Circulation. 2017. PMID: 28847797 Review.
-
Glucagon-like peptide-1 analogues for Type 2 diabetes mellitus: current and emerging agents.Drugs. 2011 Sep 10;71(13):1675-88. doi: 10.2165/11592810-000000000-00000. Drugs. 2011. PMID: 21902291 Review.
-
Differences in acute anorectic effects of long-acting GLP-1 receptor agonists in rats.Peptides. 2014 Aug;58:1-6. doi: 10.1016/j.peptides.2014.05.008. Epub 2014 May 29. Peptides. 2014. PMID: 24879927 Free PMC article.
Cited by
-
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1.Front Endocrinol (Lausanne). 2018 Oct 11;9:584. doi: 10.3389/fendo.2018.00584. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30364192 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical

